Licensing of killer dendritic cells in mouse and humans: Functional similarities between IKDC and human blood γδ T-lymphocytes

Journal of Immunotoxicology

Volumn 9, Issue 3, 2012, Pages 259-266

  Anderson, John ^a,b   Gustafsson, Kenth ^a   Himoudi, Nourredine ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

T cells; Activated NK cells; IKDC; Interferon producing killer dendritic cells; T APC

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NATURAL KILLER CELL RECEPTOR; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL KILLING; CONTROLLED STUDY; DENDRITIC CELL; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; KILLER CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MICE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA;

EID: 84865327217     PISSN: 1547691X     EISSN: None     Source Type: Journal    
DOI: 10.3109/1547691X.2012.685528     Document Type: Article

References (21)

1. + a/3-T-cell responses. Proc. Natl. Acad. Sci. USA 106:2307-2312.
2. Brandes, M., Willimann, K., and Moser, B. 2005. Professional antigen-presentation function by human yS T Cells. Science 309: 264-268. (Pubitemid 40967855)
3. Caminschi, I., Ahmet, F., Heger, K., Brady, J., Nutt, S. L., Vremec, D., Pietersz, S., Lahoud, M. H., Schofeld, L., Hansen, D. S., O'Keefe, M., Smyth, M. J., Bedoui, S., Davey, G. M., Villadangos, J. A., Heath, W. R., and Shortman, K. 2007. Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J. Exp. Med. 204:2579-2590. (Pubitemid 350044784)
4. Chan, C. W., Crafton, E., Fan, H. N., Flook, J., Yoshimura, K., Skarica, M., Brockstedt, D., Dubensky, T. W., Stins, M. F., Lanier, L. L., Pardoll, D. M., and Housseau, F. 2006. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12:207-213. (Pubitemid 43214747)
5. Chaperot, L., Blum, A., Manches, O., Lui, G., Angel, J., Molens, J. P., and Plumas, J. 2006. Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J. Immunol. 176:248-255. (Pubitemid 43023269)
6. Gober, H. J., Kistowska, M., Angman, L., Jeno, P., Mori, L., and De Libero, G. 2003. Human T-cell receptor yô cells recognize endogenous mevalonate metabolites in tumor cells. J. Exp. Med. 197:163-168. (Pubitemid 36152311)
7. Hanna, J., Gonen-Gross, T., Fitchett, J., Rowe, T., Daniels, M., Arnon, T. I., Gazit, R., Joseph, A., Schjetne, K. W., Steinle, A., Porgador, A., Mevorach, D., Goldman-Wohl, D., Yagel, S., LaBarre, M. J., Buckner, J. H, and Mandelboim, O. 2004. Novel APC-like properties of human NK cells directly regulate T-cell activation. J. Clin. Invest. 114:1612-1623. (Pubitemid 40385552)
8. Himoudi, N., Morgenstern, D. A., Yan, M., Vernay, B., Saraiva, L., Wu, Y., Cohen, C. J., Gustafsson, K., and Anderson, J. 2012. Human yô T-lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells. J. Immunol 188:1708-1716.
9. Himoudi, N., Nabarro, S., Buddle, J., Eddaoudi, A., Trasher, A. J., and Anderson, J. 2008. Bone marrow-derived IFN-producing killer dendritic cells account for the tumoricidal activity of unpulsed dendritic cells. J. Immunol. 181:6654-6663.
10. Himoudi, N., Yan, M., Bouma, G., Morgenstern, D., Wallace, R., Seddon, B., Buddle, J., Eddaoudi, A., Howe, S. J., Cooper, N., and Anderson, J. 2009. Migratory and antigen presentation functions of IFN-producing killer dendritic cells. Cancer Res. 69: 6598-6606.
11. 2+-dependent mechanism. J. Exp. Med. 186:467-472. (Pubitemid 27332906)
12. Korthals, M., Safaian, N, Kronenwett, R., Maihofer, D., Schott, M., Papewalis, C, Diaz Blanco, E., Winter, M., Czibere, A., Haas, R., Kobbe, G., and Fenk R. 2007. Monocyte derived dendritic cells generated by IFNa acquire mature dendritic and natural killer cell properties as shown by gene expression analysis. J. Transl. Med. 5:46.
13. Meuter, S., Eberl, M., and Moser, B. 2010. Prolonged antigen survival and cytosolic export in cross-presenting human yô-T-cells. Proc. Natl. Acad. Sci. USA 107:8730-8735.
14. Morita, C. T, Jin, C, Sarikonda, G., and Wang, H. 2007. Non-peptide antigens, presentation mechanisms, and immunological memory of human Vy2Vô2 T-cells: Discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol. Rev. 215:59-76. (Pubitemid 46212230)
15. Ribot, J. C, Debarros, A., and Silva-Santos, B. 2011. Searching for "signal 2": Co-stimulation requirements of yô-T-cells. Cell. Mol Life Sci. 68:2345-2355.
16. Taieb, J., Chaput, N, Menard, C, Apetoh, L., Ullrich, E., Bonmort, M., Pequignot, M., Casares, N, Terme, M., Flament, C, Opolon, P., Lecluse, Y, Metivier, D., Tomasello, E., Vivier, E., Ghiringhelli, F, Martin, F., Klatzmann, D., Poynard, T., Tursz, T., Raposo, G., Yagita, H., Ryfel, B., Kroemer, G., and Zitvogel, L. 2006. A novel dendritic cell subset involved in tumor immunosurveillance. Nat. Med. 12:214-219. (Pubitemid 43214748)
17. + subset and are licensed by tumor cells. Cancer Res. 69:6590-6597.
18. + interferon-producing killer dendritic cells are activated natural killer cells. J. Exp. Med. 204:2569-2578. (Pubitemid 350044783)
19. + lymphoid progenitors. Blood 109:4825-4931.
20. Wu, Y., Wu, W., Wong, W. M., Ward, E., Trasher, A. J., Goldblatt, D., Osman, M., Digard, P., Canaday, D. H., and Gustafsson, K. 2009. Human γδT-cells: A lymphoid lineage cell capable of professional phagocytosis. J. Immunol. 183:5622-5629.
21. Yan, M., Himoudi, N., Pule, M., Sebire, N., Poon, E., Blair, A., Williams, O., and Anderson, J. 2008. Development of cellular immune responses against PAX5, a novel target for cancer immunotherapy. Cancer Res. 68:8058-8065.